PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
1.38%
Revenue growth under 50% of MRVL's 3.14%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
2.44%
Gross profit growth under 50% of MRVL's 6.07%. Michael Burry would be concerned about a severe competitive disadvantage.
1.49%
EBIT growth below 50% of MRVL's 93.79%. Michael Burry would suspect deeper competitive or cost structure issues.
4.16%
Operating income growth under 50% of MRVL's 93.79%. Michael Burry would be concerned about deeper cost or sales issues.
0.83%
Net income growth under 50% of MRVL's 85.49%. Michael Burry would suspect the firm is falling well behind a key competitor.
0.96%
EPS growth under 50% of MRVL's 85.75%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
0.98%
Diluted EPS growth under 50% of MRVL's 85.75%. Michael Burry would worry about an eroding competitive position or excessive dilution.
No Data
No Data available this quarter, please select a different quarter.
-0.11%
Reduced diluted shares while MRVL is at 0.44%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
14.47%
Similar OCF growth to MRVL's 14.04%. Walter Schloss would assume comparable operations or industry factors.
11.93%
FCF growth above 1.5x MRVL's 7.43%. David Dodd would verify if the firm’s strategic investments yield superior returns.
66.03%
Positive 10Y revenue/share CAGR while MRVL is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
37.03%
Positive 5Y CAGR while MRVL is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
14.40%
Positive 3Y CAGR while MRVL is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
164.44%
Positive long-term OCF/share growth while MRVL is negative. John Neff would see a structural advantage in sustained cash generation.
86.38%
Below 50% of MRVL's 191.18%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
21.04%
Positive 3Y OCF/share CAGR while MRVL is negative. John Neff might see a big short-term edge in operational efficiency.
301.53%
Positive 10Y CAGR while MRVL is negative. John Neff might see a substantial advantage in bottom-line trajectory.
118.16%
5Y net income/share CAGR above 1.5x MRVL's 72.06%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
30.19%
Positive short-term CAGR while MRVL is negative. John Neff would see a clear advantage in near-term profit trajectory.
36.59%
10Y equity/share CAGR at 50-75% of MRVL's 55.52%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
28.13%
5Y equity/share CAGR at 50-75% of MRVL's 53.64%. Martin Whitman would question a shortfall in capital accumulation vs. the competitor.
21.31%
Below 50% of MRVL's 52.24%. Michael Burry suspects a serious short-term disadvantage in building book value.
688.88%
Dividend/share CAGR of 688.88% while MRVL is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
167.47%
5Y dividend/share CAGR above 1.5x MRVL's 0.07%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
64.28%
3Y dividend/share CAGR above 1.5x MRVL's 0.60%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
3.90%
AR growth well above MRVL's 1.39%. Michael Burry fears inflated revenue or higher default risk in the near future.
0.38%
Inventory shrinking or stable vs. MRVL's 2.10%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
12.96%
Positive asset growth while MRVL is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
8.95%
Positive BV/share change while MRVL is negative. John Neff sees a clear edge over a competitor losing equity.
23.80%
We have some new debt while MRVL reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
-0.77%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-3.06%
We cut SG&A while MRVL invests at 2.40%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.